港股研究社讯，据彭博社消息，强脑科技目前正就以超13亿美元的估值筹集资金展开洽谈，后续或选择 在香港或中国内地进行首次公开募股（IPO）。 有知情人士透露，这家由哈佛校友韩璧丞于2015年创立的公司，正在洽谈获取约1亿美元的IPO前融资 事宜。 该知情人士还称，这家初创企业已着手准备上市相关文件，不过上市地点及其他细节尚未确定。目前， 有关融资和IPO的讨论仍存在诸多变数，具体细节可能会随市场状况的改变而调整。截至目前，强脑科 技的代表尚未对相关置评请求作出回应。 强脑科技由哈佛大学校友韩璧丞于2015年正式创办。该公司与埃隆·马斯克（Elon Musk）旗下的脑机接 口企业Neuralink在业务领域存在竞争关系。强脑科技和DeepSeek等公司一同被并称为杭州"六小龙"，其 主要业务聚焦于开发仿生肢体技术以及人脑控制计算机的相关技术。 ...

总部位于杭州的强脑科技于2015年成立，研发及应用脑机接口技术。报道引述消息指，强脑科技正在洽 谈获得约1亿美元的上市前融资，目前公司已开始准备上市文件，但尚未确定上市地点或其他细节。 （原标题：新股消息 | 传强脑科技准备在香港或内地上市 拟以13亿美元估值募集上市前融资） 智通财经APP获悉，据报道，马斯克旗下Neuralink的竞争对手强脑科技正洽谈以超过13亿美元估值筹集 资金，准备在香港或中国内地上市。该公司正在开发仿生肢体和人脑控制计算机的技术。 ...

Group 1 - The core viewpoint of the article highlights that Zhejiang Qiangnao Technology is negotiating financing with a valuation exceeding $1.3 billion, potentially leading to an IPO in Hong Kong or mainland China [1] - Qiangnao Technology, founded by Harvard alumnus Han Bicheng in 2015, competes with Elon Musk's Neuralink and is part of the "Six Little Dragons" in Hangzhou, focusing on developing bionic limbs and brain-computer interface technologies [1] - The company is reportedly in talks for approximately $100 million in pre-IPO financing and has begun preparing the necessary documents for listing, although specific details regarding the listing location remain undecided [1] Group 2 - The financing activities of Qiangnao Technology reflect a growing interest among investors in a new generation of startups aiming to disrupt the technology sector and advance innovations in AI and robotics [1] - Qiangnao Technology is not the only Chinese startup challenging Neuralink; for instance, Shanghai Jieti Medical completed a Series B financing of 350 million RMB (approximately $48.7 million) earlier this year and initiated China's first clinical trial for an invasive brain-computer interface [1] - Han Bicheng indicated in an interview that the company is considering expanding its business into Hong Kong [1]